Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies
- 1 September 1992
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 6 (3) , 163-173
- https://doi.org/10.1016/0268-960x(92)90028-o
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- Alkylation of DNA by melphalan in relation to immunoassay of melphalan-DNA adducts: Characterization of mono-alkylated and cross-linked products from reaction of melphalan with dGMP and GMPChemico-Biological Interactions, 1990
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Fractionation of DNA from mammalian cells by alkaline elutionBiochemistry, 1976
- Antibodies to the Methylene Blue Sensitized Photooxidation Product in Deoxyribonucleic Acid*Biochemistry, 1966
- The reaction of mono- and di-functional alkylating agents with nucleic acidsBiochemical Journal, 1961
- Potential Anticancer Agents--XXXL. The Relationship of Analogues of 1-Methyl-3-nitro-1-nitrosoguanidine (NSC-9369)Journal of Medicinal Chemistry, 1960
- Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalaninesJournal of the Chemical Society, 1954
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENTThe Lancet, 1953
- The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and SulfidesScience, 1946